AAAAAA

   
Results: 1-25 |
Results: 25

Authors: Alarcon-Segovia, D Shoenfeld, Y
Citation: D. Alarcon-segovia et Y. Shoenfeld, Mexico-Israel Symposium - (February 15-16, 2001 Mexico City), ISR MED ASS, 3(2), 2001, pp. 84-84

Authors: Ruiz-Arguelles, A Alarcon-Segovia, D
Citation: A. Ruiz-arguelles et D. Alarcon-segovia, Penetration of autoantibodies into living cells, 2000, ISR MED ASS, 3(2), 2001, pp. 121

Authors: Alarcon-Segovia, D
Citation: D. Alarcon-segovia, The future of treatment for systemic lupus erythematosus, ISR MED ASS, 3(2), 2001, pp. 127-130

Authors: Alarcon-Segovia, D Drenkard, C Villa, AR
Citation: D. Alarcon-segovia et al., Survival of Mexican patients with systemic lupus erythematosus, RHEUMATOLOG, 40(2), 2001, pp. 228-228

Authors: Alarcon-Segovia, D
Citation: D. Alarcon-segovia, The recovery of self tolerance in SLE, LUPUS, 10(8), 2001, pp. 521-522

Authors: Alarcon-Segovia, D
Citation: D. Alarcon-segovia, Antinuclear antibodies: to penetrate or not to penetrate, that was the question, LUPUS, 10(5), 2001, pp. 315-318

Authors: Vargas-Alarcon, G Salgado, N Granados, J Gomez-Casado, E Martinez-Laso, J Alcocer-Varela, J Arnaiz-Villena, A Alarcon-Segovia, D
Citation: G. Vargas-alarcon et al., Class II allele and haplotype frequencies in Mexican systemic lupus erythematosus patients: The relevance of considering homologous chromosomes in determining susceptibility, HUMAN IMMUN, 62(8), 2001, pp. 814-820

Authors: Ruiz-Arguelles, A Alarcon-Segovia, D
Citation: A. Ruiz-arguelles et D. Alarcon-segovia, Novel facts about an old marker: the LE cell, SC J CL INV, 61, 2001, pp. 31-37

Authors: Drenkard, C Alarcon-Segovia, D
Citation: C. Drenkard et D. Alarcon-segovia, The new prognosis of systemic lupus erythematosus: Treatment-free remission and decreased mortality and morbidity, ISR MED ASS, 2(5), 2000, pp. 382-387

Authors: Alarcon-Segovia, D Cabral, AR
Citation: D. Alarcon-segovia et Ar. Cabral, The anti-phospholipid antibody syndrome: clinical and serological aspects, BEST PR R C, 14(1), 2000, pp. 139-150

Authors: Alarcon-Segovia, D Drenkard, C
Citation: D. Alarcon-segovia et C. Drenkard, Vasculitis and the antiphospholipid syndrome, RHEUMATOLOG, 39(8), 2000, pp. 922-923

Authors: Villa, AR Kraus, A Jimenez-Corona, A Sandino, S Velazquez-Gonzalez, A Granados, J Alarcon-Segovia, D
Citation: Ar. Villa et al., Malignant neoplasms in autoimmune rheumatic diseases - Examination of the risk of developing a malignancy among five different rheumatic diseased in one institution, JCR-J CLIN, 6(4), 2000, pp. 176-183

Authors: Montilla, C Alarcon-Segovia, D
Citation: C. Montilla et D. Alarcon-segovia, Anetoderma in systemic lupus erythematosus: relationship to antiphospholipid antibodies, LUPUS, 9(7), 2000, pp. 545-547

Authors: Alarcon-Segovia, D Perez-Ruiz, A Villa, AR
Citation: D. Alarcon-segovia et al., Long-term prognosis of antiphospholipid syndrome in patients with systemiclupus erythematosus, J AUTOIMMUN, 15(2), 2000, pp. 157-161

Authors: Magnusson, V Lindqvist, AKB Castillejo-Lopez, C Kristjansdottir, H Steinsson, K Grondal, G Sturfelt, G Truedsson, L Svenungsson, E Lundberg, I Gunnarsson, I Bolstad, AI Haga, HJ Jonsson, R Klareskog, L Alcocer-Varela, J Alarcon-Segovia, D Terwilliger, JD Gyllensten, UB Alarcon-Riquelme, ME
Citation: V. Magnusson et al., Fine mapping of the SLEB2 locus involved in susceptibility to systemic lupus erythematosus, GENOMICS, 70(3), 2000, pp. 307-314

Authors: Alarcon-Segovia, D
Citation: D. Alarcon-segovia, Kidney transplantation is a safe therapeutic tool in systemic lupus erythematosus, CLIN EXP RH, 18(2), 2000, pp. 185-186

Authors: Llorente, L Richaud-Patin, Y Garcia-Padilla, C Claret, E Jakez-Ocampo, J Cardiel, MH Alcocer-Varela, J Grangeot-Keros, L Alarcon-Segovia, D Wijdenes, J Galanaud, P Emilie, D
Citation: L. Llorente et al., Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus, ARTH RHEUM, 43(8), 2000, pp. 1790-1800

Authors: Ruiz-Arguelles, GJ Garces-Eisele, J Ruiz-Delgado, GJ Alarcon-Segovia, D
Citation: Gj. Ruiz-arguelles et al., The G20210A polymorphism in the 3 '-untranslated region of the prothrombingene in Mexican mestizo patients with primary antiphospholipid syndrome, CL APPL T-H, 5(3), 1999, pp. 158-160

Authors: Alarcon-Segovia, D
Citation: D. Alarcon-segovia, Treatment needed to achieve remission of SLE, LUPUS, 8(7), 1999, pp. 566-566

Authors: Alarcon-Segovia, D
Citation: D. Alarcon-segovia, How long does it take to describe 25 SLE antigen antibody systems?, LUPUS, 8(4), 1999, pp. 332-332

Authors: Johanneson, N Steinsson, K Lindqvist, AK Kristjansdottir, H Grondal, G Sandino, S Tjernstrom, F Sturfelt, G Granados-Arriola, J Alcocer-Varela, J Lundberg, I Jonasson, I Truedsson, L Svenungssons, E Klareskog, L Alarcon-Segovia, D Gyllensten, UB Alarcon-Riquelme, ME
Citation: N. Johanneson et al., A comparison of genome-scans performed in multicase families with systemiclupus erythematosus from different population groups, J AUTOIMMUN, 13(1), 1999, pp. 137-141

Authors: Weckmann, AL Granados, J Cardiel, MH Andrade, F Vargas-Alarcon, G Alcocer-Varela, J Alarcon-Segovia, D
Citation: Al. Weckmann et al., Immunogenetics of mixed connective tissue disease in a Mexican Mestizo population, CLIN EXP RH, 17(1), 1999, pp. 91-94

Authors: Alarcon-Riquelme, ME Lindqvist, AKB Jonasson, I Johanneson, B Sandino, S Alcocer-Varela, J Granados, J Kristjansdottir, H Grondal, G Svenungsson, E Lundberg, I Steinsson, K Klareskog, L Sturfelt, G Truedsson, L Alarcon-Segovia, D Gyllensten, UB
Citation: Me. Alarcon-riquelme et al., Genetic analysis of the contribution of IL10 to systemic lupus erythematosus, J RHEUMATOL, 26(10), 1999, pp. 2148-2152

Authors: Gomez-Pacheco, L Villa, AR Drenkard, C Cabiedes, J Cabral, AR Alarcon-Segovia, D
Citation: L. Gomez-pacheco et al., Serum anti-beta(2)-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients, AM J MED, 106(4), 1999, pp. 417-423

Authors: Alarcon-Segovia, D Cabral, AR
Citation: D. Alarcon-segovia et Ar. Cabral, Clinical associations of antibodies to phospholipids and or their protein cofactors, DECADE OF AUTOIMMUNITY, 1999, pp. 75-79
Risultati: 1-25 |